Affilate Marketing Inside Scoop
Let’s get the bad news out of the way first. Marketing Sherpas research has shown that your email subscriber list is most likely going to degrade by about 22.5% every year. For various reasons: Subscribers’ email addresses change as they move from one company to another Unqualified leads opt out
Read More
AdMaven’s mission is to generate for our customers as much value as we can. We do it by providing you the best traffic. We do it by giving you the best support. We do it by giving you the best advice. We do it by helping you to make the
Read More
Calendar year 2018 has been unprecedented in terms of international and domestic privacy legislation. From the European Union General Data Protection Regulation to states’ enactment of more restrictive data privacy laws, and from Federal Trade Commission actions to the fake news scandals, companies are expending significant resources on compliance. There has
Read MoreIt's that time of year again when both the spending and donations increase significantly. It's the season that presents all small business with huge opportunities to gain even further sales. To help maximize your results this holiday season, you should start engaging your audience via your email marketing efforts immediately. Constant
Read More
For us affiliate marketers, the landing page is the messiah to lead generation. It gives marketers the ability to dive all into any niche and convert cold traffic into treasured leads. Once upon a time though in the not so distant past, landing pages were not the clean, polished, glamorous, and
Read MoreAlmost 89 percent of users do not return to an app one week after first installing and/or using it. That number seems insane, however it's all apart of the details in the new Global Benchmarks 2.0 report from mobile measurement and fraud prevention firm Adjust. The new and improved version of the already powerful report provides
Read More
A California-based physician and the companies that he controls have settled charges by the Federal Trade Commission that “amniotic stem cell therapy” can treat serious diseases, such as Parkinson’s disease, autism, macular degeneration, cerebral palsy, multiple sclerosis and heart attacks. As set forth in the complaint, the defendants earned millions of
Read More